articleThe Lancet OncologyFeb 20, 2016Closed access

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

JSJennifer S. TemelAPAmy P. AbernethyDCDavid C. CurrowJFJohn FriendEMElizabeth Manning Duus

Massachusetts General Hospital · Duke University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

620
total citations
FWCI
45.04
Percentile
100%
References
32
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Cachexia
  • Medicine
  • Cancer cachexia
  • Lung cancer
  • Double blind
  • Cancer
  • Clinical trial
  • Oncology
No related works found for this paper.

Funding